|
1 |
An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT)
Pauck, David. - Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2025
|
|
|
|
2 |
An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT)
Pauck, David. - Augsburg : Universität Augsburg, 2025
|
|
|
|
3 |
Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models
Sigaud, Romain. - Freiburg : Universität, 2025
|
|
|
|
4 |
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47- induced macrophage phagocytosis via NF- kB- TGM2 driven tumor inflammation
Marquardt, Viktoria. - London : BMJ Publishing Group Ltd, 2025
|
|
|
5 |
Impact of shrub branches on the shortwave vertical irradiance profile in snow
Enthalten in EGUsphere 24.06.2024: 1-27. 27 S.
|
|
|
|
6 |
MAP-IO, an atmospheric and marine observatory program onboard <em>Marion Dufresne</em> over the Southern Ocean
Enthalten in Earth system science data discussions 27.02.2024: 1-43. 43 S.
|
|
|
|
7 |
Optical Trapping and Fast Discrimination of Label‐Free Bacteriophages at the Single Virion Level
Enthalten in Small 28.01.2024. 9 S.
|
|
|
|
8 |
CD155 is a putative therapeutic target in medulloblastoma
Enthalten in Clinical and translational oncology 27.10.2022: 1-10
|
|
|
|
9 |
Progenitor cells derived from gene‐engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology
Enthalten in Biotechnology journal 03.04.2022. 13 S.
|
|
|
|
10 |
Identification of Germline Non-coding Deletions in XIAP Gene Causing XIAP Deficiency Reveals a Key Promoter Sequence
Enthalten in Journal of clinical immunology 9.1.2022: 1-13
|
|
Administration
